Facts about safety and side effects.

HPV vaccination can help reduce your child’s risk of certain HPV-related cancers later in life.

But as a parent, you might be wondering if there are risks associated with the HPV vaccine itself. The Centers for Disease Control and Prevention (CDC) monitors the safety of the HPV vaccine during the post-licensure period.

For more information on GARDASIL 9, talk to your child’s doctor at their next visit.

GARDASIL^®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.

GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL 9 does not prevent all types of cervical, vulvar, vaginal, anal or head and neck cancers. Vaccination does not remove the need for recommended screenings for these cancers, and it’s important for girls to get routine cervical cancer screenings later in life. GARDASIL 9 does not treat cancer or genital warts.

GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.

For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6–12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
For persons 15 through 45 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.

The appropriate dosing schedule will be determined by your child’s health care professional.

Anyone who is allergic to the ingredients of GARDASIL^®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) or GARDASIL^® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

Anyone who is allergic to the ingredients of GARDASIL 9 or GARDASIL^® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

The side effects include pain, swelling, redness, itching, bruising, bleeding, and a lump where your child got the shot, headache, fever, nausea, and dizziness. Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, your health care professional may ask your child to sit or lie down for 15 minutes after your child gets GARDASIL 9. Some people who faint might shake or become stiff.

Only a doctor or health care professional can decide if GARDASIL 9 is right for your child.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for GARDASIL 9, and discuss it with your doctor. The physician Prescribing Information also is available.

GARDASIL 9 SAFETY & SIDE EFFECTS

Facts about safety and side effects.

Information About GARDASIL 9

Important Safety Information

Important Safety Information